BOSTON, MA – November 3, 2022 – CRIO, the industry’s leading eSource provider, announces the appointment of Dr. Margaretta Nyilas to its Board of Directors, effective immediately. Dr. Nyilas is a biopharmaceutical executive with over twenty years of diverse global industry experience, formerly at Otsuka Pharmaceuticals, Bristol Myers Squibb and Click Therapeutics. She has a...
Running a Study
This document describes CRIO’s integrated eSource/EDC model, in which source data is collected electronically by the site using CRIO’s eSource system, then transmitted automatically to CRIO’s Reviewer module or to legacy EDC systems, which allows sponsors to review, query, code, lock and extract the data. This model unlocks significant savings for the sponsor/CRO, mainly by...
CRIO Company News
BOSTON, MA – August 9, 2022 – CRIO, a Boston-based healthcare technology company streamlining clinical trials for sponsors, sites and patients, announced that it has reached another milestone, exceeding 2,000 clinical research sites standardizing on CRIO’s eSource platform. CRIO supports a variety of clinical trial data. To date, over 800 life science sponsors have data...
CRIO Company News
CRIO, the leader in eSource technology, is announcing the launch of an industry first, CRIO Reviewer, designed to create a fully integrated eSource/EDC system. Reviewer allows sponsors and CROs to review, query, extract, code and lock data collected in the CRIO eSource application within minutes of site completion. This solution enables research sites to capture...
CRIO Company News
Company Strengths Executive Management Team with Senior Industry Expert BOSTON, MA – April 19, 2022 – Clinical Research IO (CRIO), a Boston-based technology firm streamlining clinical trials for sponsors, sites, and patients, announced that Jonathan Andrus will join as President and Chief Operating Officer. Working collaboratively with the CRIO senior team, Andrus will focus on...
